Jacobus Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$5.26M Hold
59,210
1.38% 23
2017
Q2
$4.29M Hold
59,210
1.16% 24
2017
Q1
$3.86M Buy
59,210
+63
+0.1% +$3.96K 1.08% 26
2016
Q4
$3.7M Sell
59,147
-1
-0% -$61 1.08% 25
2016
Q3
$3.73M Buy
59,148
+1
+0% +$65 1.09% 26
2016
Q2
$3.66M Sell
59,147
-3,117
-5% -$190K 1.12% 26
2016
Q1
$3.56M Buy
62,264
+20
+0% +$1.11K 1.04% 24
2015
Q4
$3.69M Sell
62,244
-130
-0.2% -$7.49K 1.06% 25
2015
Q3
$3.39M Sell
62,374
-1,549
-2% -$101K 0.99% 27
2015
Q2
$4.29M Buy
63,923
+512
+0.8% +$33.4K 1.07% 27
2015
Q1
$3.71M Sell
63,411
-770
-1% -$46.5K 0.96% 28
2014
Q4
$4.2M Sell
64,181
-975
-1% -$61.5K 1.09% 27
2014
Q3
$3.76M Buy
65,156
+584
+0.9% +$32.4K 1.04% 25
2014
Q2
$3.64M Sell
64,572
-600
-0.9% -$31.5K 0.93% 28
2014
Q1
$3.35M Buy
+65,172
New +$3.29M 0.81% 29
2013
Q4
Sell
-63,516
Closed -$2.84M 309
2013
Q3
$2.84M Hold
63,516
0.99% 27
2013
Q2
$2.63M Buy
+63,516
New +$2.78M 0.96% 25

Other funds holding ABBV

Jacobus Wealth Management's ABBV Position: Q3 2017 in Review

Jacobus Wealth Management held its AbbVie (ABBV) position steady in Q3 2017 at 59,210 shares worth $5.26M. The position accounts for 1.38% of the portfolio, ranked #23.

Jacobus Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Jacobus Wealth Management held 59,210 shares of AbbVie worth $5.26M as of Q3 2017.
  • Jacobus Wealth Management left its AbbVie share count unchanged in Q3 2017.
  • AbbVie made up 1.38% of Jacobus Wealth Management's portfolio in Q3 2017, its #23 holding.
  • Jacobus Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Jacobus Wealth Management's 13F filing for Q3 2017, filed 31 Oct 2017.